Welcome to the first episode of The Finance Show, your biweekly briefing on Belgian and global corporate finance.
Belgian Deals
GBL commits €500M to Rayner Surgical, making a major bet on the ophthalmology sector and marking one of the largest Belgian healthcare deals of the year.
John Cockerill raises €300M to accelerate its green hydrogen and industrial transformation strategy across Europe and beyond.
Agomab Therapeutics goes public on Nasdaq, raising $200M in one of Belgium's most closely watched biotech IPOs in recent years.
Global M&A
The battle for Warner Bros Discovery is heating up. Netflix enters the race with an $83B bid while Paramount Skydance counters with $108B. We break down the competing offers, what each buyer brings to the table, and why this deal matters for the future of streaming.
Trump's new tariff announcements and their potential ripple effects on European deal-making.
Analysis, context, and what's next. All in one episode.
